Maravai LifeSciences Holdings, Inc. (MRVI)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-25) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-11) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-12) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-18) · 99.1 | 8-K (2025-02-25) · 99.1 | 8-K (2025-01-08) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-07) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-08) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-22) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-07) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Changes In Stockholders Equity | ||
| Consolidated Statements of Comprehensive (loss) Income | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Acquisitions | ||
| Acquisitions and Divestiture | — |
|
| Balance Sheet Components | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Benefit Plans | — |
|
| Equity Incentive Plans | — |
|
| Fair Value Measurements | ||
| Goodwill and Intangible Assets | ||
| Government Assistance | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Long-term Debt | ||
| Net (loss) Income Per Class A Common Share Attributable To Maravai Lifesciences Holdings, Inc. | ||
| Net Loss Per Class A Common Share Attributable To Maravai Lifesciences Holdings, Inc. | ||
| Organization and Significant Accounting Policies | ||
| Pay Vs Performance Disclosure | ||
| Quarterly Financial Information (unaudited) | — |
|
| Related Party Transactions | ||
| Restructuring | ||
| Segments | ||
| Stock-based Compensation | — |
|
| Stockholders Equity | — |
|
| Subsequent Events | ||